Literature DB >> 19253487

Measurement of clinical-effect: utility.

Phantipa Sakthong1.   

Abstract

The utility approach to assessing health-related quality of life is the most widely used technique for assessing preferences for health outcomes in the economic evaluation of health care. The scale for utility scores assigns a value of 1.0 to perfect health and 0.0 to death. The utility scores are employed to weigh time spent in each health state to estimate quality-adjusted life years (QALYs) gained, which is used as the denominator in cost-utility analysis and cost-effectiveness analysis. Utility scores are obtained through direct assessments using techniques such as standard gamble (SG), time-trade off (TTO), and visual analog scale (VAS), or by using multi-attribute systems such as the Health Utilities Index (HUI) or EuroQol (EQ-5D). According to international HE guidelines, the most preferred utility methods are SG and TTO, followed by EQ-5D, VAS and HUI, respectively In Thailand, the EQ-5D is the most recommended utility method because it has acceptable feasibility and validity.

Mesh:

Year:  2008        PMID: 19253487

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  13 in total

1.  Psychometric properties of the EQ-5D-5L in Thai patients with chronic diseases.

Authors:  Phantipa Sakthong; Nontapat Sonsa-Ardjit; Pattarin Sukarnjanaset; Wipaporn Munpan
Journal:  Qual Life Res       Date:  2015-06-06       Impact factor: 4.147

2.  Exploration of a cultural-adaptation of the EQ-5D for Thai population: A "bolt-on" experiment.

Authors:  Krittaphas Kangwanrattanakul; Cynthia R Gross; Montaya Sunantiwat; Montarat Thavorncharoensap
Journal:  Qual Life Res       Date:  2018-12-05       Impact factor: 4.147

3.  Utility Index and Patient-Reported Outcome Measures in Glaucomatous Patients Comparing with Normal Participants.

Authors:  Kulawan Rojananuangnit; Nuttawan Sudjinda
Journal:  Clin Ophthalmol       Date:  2021-02-25

4.  Health related quality of life among patients with tuberculosis and HIV in Thailand.

Authors:  Wanitchaya Kittikraisak; Pritaporn Kingkaew; Yot Teerawattananon; Jomkwan Yothasamut; Supalert Natesuwan; Weerawat Manosuthi; Virasakdi Chongsuvivatwong; Sara J Whitehead
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

5.  Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients.

Authors:  Juntana Pattanaphesaj; Montarat Thavorncharoensap
Journal:  Health Qual Life Outcomes       Date:  2015-02-06       Impact factor: 3.186

6.  Willingness to pay per quality-adjusted life year for life-saving treatments in Thailand.

Authors:  Khachapon Nimdet; Surachat Ngorsuraches
Journal:  BMJ Open       Date:  2015-10-05       Impact factor: 2.692

7.  The Indonesian EQ-5D-5L Value Set.

Authors:  Fredrick Dermawan Purba; Joke A M Hunfeld; Aulia Iskandarsyah; Titi Sahidah Fitriana; Sawitri Supardi Sadarjoen; Juan Manuel Ramos-Goñi; Jan Passchier; Jan J V Busschbach
Journal:  Pharmacoeconomics       Date:  2017-11       Impact factor: 4.981

8.  An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand.

Authors:  Kittiphong Thiboonboon; Pattara Leelahavarong; Duangrurdee Wattanasirichaigoon; Nithiwat Vatanavicharn; Pornswan Wasant; Vorasuk Shotelersuk; Suthipong Pangkanon; Chulaluck Kuptanon; Sumonta Chaisomchit; Yot Teerawattananon
Journal:  PLoS One       Date:  2015-08-10       Impact factor: 3.240

9.  Variation of health-related quality of life assessed by caregivers and patients affected by severe childhood infections.

Authors:  Wantanee Kulpeng; Vorasith Sornsrivichai; Virasakdi Chongsuvivatwong; Waranya Rattanavipapong; Pattara Leelahavarong; John Cairns; Yoel Lubell; Yot Teerawattananon
Journal:  BMC Pediatr       Date:  2013-08-13       Impact factor: 2.125

10.  The cost utility and budget impact of adjuvant racecadotril for acute diarrhea in children in Thailand.

Authors:  Tamlyn Anne Rautenberg; Ute Zerwes
Journal:  Clinicoecon Outcomes Res       Date:  2017-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.